Search for:

In brief

The Anti-Corruption Office (OA) has enabled the registration and use of the Registry of Integrity and Transparency of Companies and Entities (RITE), after announcing its establishment in April 2021.

The purpose of the RITE is to contribute to the development, improvement and maturity of the integrity programs as provided for in Law 27,401; the exchange of good practices; and promote transparent business and market environments.

The OA held several meetings and agreements with public and private entities in preparation for the launch.

In focus

18 months after making the announcement, the OA has finally enabled the RITE through Resolution 03/2021. It can be accessed through its website, from where material can be obtained and organizations can provisionally join the registry by email.

The purpose of the RITE is to contribute to the development, improvement and maturity of the integrity of corruption programs, the exchange of good practices, and the promotion of transparent environments for businesses and markets.

Likewise, the portal offers a number of useful tools such as Integrity Program forms for companies, or integrity channel management guides and documents to follow up on training.

The OA entered into various agreements with public and private entities, and it held meetings with professionals specialized in the matter. Meetings were held to work on the different contributions, and the forms that must be completed in the RITE portal for registration were prepared.

Registration to the RITE is voluntary and is intended for companies and entities, both public and private, in order to give greater visibility to the commitment to transparency and ethical standards.

Although registration to the RITE is voluntary, if a state supplier company does not register, it must present an affidavit evidencing the existence and content of its Integrity Programs, pursuant to Law No. 27,401.

Click here to access the Spanish version.


Vanina Caniza is a partner in Baker McKenzie’s Buenos Aires office and the Global Chair of the Healthcare & Life Sciences Group. She advises a range of multinational, Latin America and Argentine clients in a variety of corporate and commercial law matters, with extensive experience in corporate compliance, commercial agreements, mergers & acquisitions and regulatory advice. Vanina has extensive knowledge in the pharmaceutical, biotech and medical device sectors. She completed postgraduate courses on Biotechnology at Universidad Torcuato di Tella (Buenos Aires) and on Health Law at Universidad de Buenos Aires. She was previously the Latin America Leader of the Healthcare & Life Sciences Group and also sits on the Steering Committee of the Firm’s Latin America Corporate Compliance Group. She is currently a professor in the CEC Compliance & Ethics Certification (AAEC-UCEMA).


Nicolás Servente is an Associate in Baker McKenzie Buenos Aires office.

Write A Comment